Cannabis Pharmaceuticals Market

May 2021| MRS228A| Market Research Studies

Report Highlights

The report broadly covers different brand of cannabis based on their compound type. Furthermore, the scope of the report also covers the impact of COVID-19 and drivers and challenges for cannabis pharmaceuticals market. The report covers the market value for the historic year 2019, followed by the base year 2020, estimated year 2021 and forecast period from 2020 to 2026 for each brand, compound type, distribution channel, and regional markets, and the estimated values are derived from the manufacturers’ total revenues.

The report also includes a discussion of the major players across each of the regional cannabis pharmaceuticals markets; it explains the major market drivers of the global cannabis pharmaceuticals industry, current trends within the industry, major applications, and the regional dynamics of the global cannabis pharmaceuticals market.

The report concludes with a special focus on the vendor landscape, which includes detailed profiles of the major vendors in the global cannabis pharmaceuticals market.

Report Includes

  • 37 tables and 45 figures
  • An up-to-date analysis of the Global Cannabis Pharmaceuticals Market.
  • Analyses of the global market trends, with data from 2019, 2020, estimates for 2021, and projections of compound annual growth rates (CAGRs) through 2026.
  • Estimation of market size and revenue forecast for Global Cannabis Pharmaceuticals Market, and corresponding market share analysis by brand, compound type, distribution channel, and region.
  • Highlights of emerging technology trends, gaps and opportunities in the market estimating current and future demand for Cannabis Pharmaceuticals, identification of the companies that are best positioned to meet this demand.
  • In-depth information (facts and figures) concerning market drivers, restraints and other forces affecting the progress of this market.
  • Identification of promising new products still in the development and testing stages, and their probability of successful commercial launch within the next five years
  • Impact of COVID-19 on the Cannabis Pharmaceuticals Market as compared to overall global economy.
  • Insight into the growth development strategies of major Cannabis Pharmaceuticals manufacturers and their key competitive landscape
  • Descriptive company profiles of the leading market participants, including GW Pharmaceuticals, plc, AbbVie Inc., Insys Therapeutics, Inc., Corbus Pharmaceuticals Holdings Inc., Teva Pharmaceutical Industries Ltd., Avicanna Inc., Solvay S.A., Cannabis Pharmaceuticals Inc., and others.

Summary

Cannabis commonly known as marijuana refers to a cluster of three plants with psychotropic properties, namely Cannabis sativa, Cannabis ruderalis, and Cannabis indica. Cannabis is quite safe and has lesser side effects when compared to other treatment methods.

Cannabis is effectively used to treat symptoms such as, reducing nausea, vomiting, and many other conditions. The emergence of Cannabis 3.0 has effectively highlighted the requirement of value-based outcomes instead of perception-based outcomes. In this method, there is a sift of the usage of tradition method of smoking the whole cannabis flower to the uptake of the processed, and packaged cannabis derived products.

There is a movement of certifying the use of medical cannabis by the major players operational in the market. Recently, Eqalis Pharmaceuticals, a New Zealand-based therapeutic cannabis company, received an industrial license to manufacture medicines which are cannabis-infused for the sales in the domestic market. The aging population is one of the prime reasons for the increasing in the growth of cannabis across the global.

The Global Cannabis Pharmaceuticals Market was valued around $140 million in 2020 and is expected to witness a steady growth at a CAGR of 71.3% during the forecast period.

  • Table 1 : Global Cannabis Pharmaceuticals Market, Through 2026
  • Table 2 : Global Cannabis Pharmaceuticals Market, by Brand, Through 2026
  • Table 3 : Global Cannabis Pharmaceuticals Market, by Compound Type, Through 2026
  • Table 4 : Global Cannabis Pharmaceuticals Market, by Distribution Channel, Through 2026
  • Table 5 : Global Cannabis Pharmaceuticals Market, by Region, Through 2026
  • Table 6 : North America Cannabis Pharmaceuticals Market, by Brand, Through 2026
  • Table 7 : North America Cannabis Pharmaceuticals Market, by Compound Type, Through 2026
  • Table 8 : North America Cannabis Pharmaceuticals Market, by Distribution Channel, Through 2026
  • Table 9 : North America Cannabis Pharmaceuticals Market, by Country, Through 2026
  • Table 10 : Europe Cannabis Pharmaceuticals Market, by Brand, Through 2026
  • Table 11 : Europe Cannabis Pharmaceuticals Market, by Compound Type, Through 2026
  • Table 12 : Europe Cannabis Pharmaceuticals Market, by Distribution Channel, Through 2026
  • Table 13 : Europe Cannabis Pharmaceuticals Market, by Country, Through 2026
  • Table 14 : Asia-Pacific Cannabis Pharmaceuticals Market, by Brand, Through 2026
  • Table 15 : Asia-Pacific Cannabis Pharmaceuticals Market, by Compound Type, Through 2026
  • Table 16 : Asia-Pacific Cannabis Pharmaceuticals Market, by Distribution Channel, Through 2026
  • Table 17 : Asia-Pacific Cannabis Pharmaceuticals Market, by Country, Through 2026
  • Table 18 : South America Cannabis Pharmaceuticals Market, by Brand, Through 2026
  • Table 19 : South America Cannabis Pharmaceuticals Market, by Compound Type, Through 2026
  • Table 20 : South America Cannabis Pharmaceuticals Market, by Distribution Channel, Through 2026
  • Table 21 : South America Cannabis Pharmaceuticals Market, by Country, Through 2026
  • Table 22 : Middle East & Africa Cannabis Pharmaceuticals Market, by Brand, Through 2026
  • Table 23 : Middle East & Africa Cannabis Pharmaceuticals Market, by Compound Type, Through 2026
  • Table 24 : Middle East & Africa Cannabis Pharmaceuticals Market, by Distribution Channel, Through 2026
  • Table 25 : Middle East & Africa Cannabis Pharmaceuticals Market, by Country, Through 2026
  • Table 26 : GW Pharmaceuticals, plc: Financial Performance, Through 2020
  • Table 27 : AbbVie Inc.: Financial Performance, Through 2020
  • Table 28 : Insys Therapeutics, Inc.: Financial Performance, Through 2020
  • Table 29 : Corbus Pharmaceuticals Holdings Inc.: Financial Performance, Through 2020
  • Table 30 : Teva Pharmaceutical Industries Ltd.: Financial Performance, Through 2020
  • Table 31 : Avicanna Inc.: Financial Performance, Through 2020
  • Table 32 : Solvay S.A.: Financial Performance, Through 2020
  • Table 33 : Cannabis Pharmaceuticals Inc.: Financial Performance, Through 2020
  • Table 34 : Tilray Inc.: Financial Performance, Through 2020
  • Table 35 : CURE Pharmaceutical Holding Corp.: Financial Performance, Through 2020
  • Table 36 : Zynerba Pharmaceuticals, Inc.: Financial Performance, Through 2020
  • Table 37 : Endo International plc: Financial Performance, Through 2020
  • Figure 1 : Global Cannabis Pharmaceuticals Market
  • Figure 2 : Global Cannabis Pharmaceuticals Market, by Value, 2019-2026
  • Figure 3 : Global Cannabis Pharmaceuticals Market, by Value, by Brand, 2019-2026
  • Figure 4 : Global Cannabis Pharmaceuticals Market, by Value, by Compound Type, 2019-2026
  • Figure 5 : Global Cannabis Pharmaceuticals Market, by Value, by Distribution Channel, 2019-2026
  • Figure 6 : Global Cannabis Pharmaceuticals Market, by Value, by Region, 2020
  • Figure 7 : Global Cannabis Pharmaceuticals Market, by Value, by Company, 2020
  • Figure 8 : Global Cannabis Pharmaceuticals Market, Product Map, 2020
  • Figure 9 : North America Cannabis Pharmaceuticals Market, by Value, 2019-2026
  • Figure 10 : North America Cannabis Pharmaceuticals Market, by Value, by Brand, 2019-2026
  • Figure 11 : North America Cannabis Pharmaceuticals Market, by Value, by Compound Type, 2019-2026
  • Figure 12 : North America Cannabis Pharmaceuticals Market, by Value, by Distribution Channel, 2019-2026
  • Figure 13 : North America Cannabis Pharmaceuticals Market, by Value, by Country, 2020
  • Figure 14 : Europe Cannabis Pharmaceuticals Market, by Value, 2019-2026
  • Figure 15 : Europe Cannabis Pharmaceuticals Market, by Value, by Brand, 2019-2026
  • Figure 16 : Europe Cannabis Pharmaceuticals Market, by Value, by Compound Type, 2019-2026
  • Figure 17 : Europe Cannabis Pharmaceuticals Market, by Value, by Distribution Channel, 2019-2026
  • Figure 18 : Europe Cannabis Pharmaceuticals Market, by Value, by Country, 2020
  • Figure 19 : Asia-Pacific Cannabis Pharmaceuticals Market, by Value, 2019-2026
  • Figure 20 : Asia-Pacific Cannabis Pharmaceuticals Market, by Value, by Brand, 2019-2026
  • Figure 21 : Asia-Pacific Cannabis Pharmaceuticals Market, by Value, by Compound Type, 2019-2026
  • Figure 22 : Asia-Pacific Cannabis Pharmaceuticals Market, by Value, by Distribution Channel, 2019-2026
  • Figure 23 : Asia-Pacific Cannabis Pharmaceuticals Market, by Value, by Country, 2020
  • Figure 24 : South America Cannabis Pharmaceuticals Market, by Value, 2019-2026
  • Figure 25 : South America Cannabis Pharmaceuticals Market, by Value, by Brand, 2019-2026
  • Figure 26 : South America Cannabis Pharmaceuticals Market, by Value, by Compound Type, 2019-2026
  • Figure 27 : South America Cannabis Pharmaceuticals Market, by Value, by Distribution Channel, 2019-2026
  • Figure 28 : South America Cannabis Pharmaceuticals Market, by Value, by Country, 2020
  • Figure 29 : Middle East & Africa Cannabis Pharmaceuticals Market, by Value, 2019-2026
  • Figure 30 : Middle East & Africa Cannabis Pharmaceuticals Market, by Value, by Brand, 2019-2026
  • Figure 31 : Middle East & Africa Cannabis Pharmaceuticals Market, by Value, by Compound Type, 2019-2026
  • Figure 32 : Middle East & Africa Cannabis Pharmaceuticals Market, by Value, by Distribution Channel, 2019-2026
  • Figure 33 : Middle East & Africa Cannabis Pharmaceuticals Market, by Value, by Country, 2020
  • Figure 34 : GW Pharmaceuticals, plc: Revenue Share, 2020
  • Figure 35 : AbbVie Inc.: Revenue Share, 2020
  • Figure 36 : Insys Therapeutics, Inc.: Revenue Share, 2020
  • Figure 37 : Corbus Pharmaceuticals Holdings Inc.: Revenue Share, 2020
  • Figure 38 : Teva Pharmaceutical Industries Ltd.: Revenue Share, 2020
  • Figure 39 : Avicanna Inc.: Revenue Share, 2020
  • Figure 40 : Solvay S.A.: Revenue Share, 2020
  • Figure 41 : Cannabis Pharmaceuticals Inc.: Revenue Share, 2020: Revenue Share, 2020
  • Figure 42 : Tilray Inc.: Revenue Share, 2020
  • Figure 43 : CURE Pharmaceutical Holding Corp.: Revenue Share, 2020
  • Figure 44 : Zynerba Pharmaceuticals, Inc.: Revenue Share, 2020
  • Figure 45 : Endo International plc: Revenue Share, 2020

Market Research Studies is a North Carolina based, premier market research company. MRS brings over 50 years of market research publishing experience. Our reports cover a variety of industries such as Healthcare, Chemicals, Materials & Manufacturing, Research & Diagnostics, Environment & Sustainability, among others. Each year MRS releases hundreds of reports covering various topics. These reports are prepared by our in-house of team of Industry expert analysts. We strive to provide in-depth market analysis with accurate data to help our customers make informed decisions.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report